Clinical Trials
20 trialsNCT03937830 2026-06-05
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT07630610 2026-06-05
Feasibility and Safety of Augmented Reality (AR) in Liver Tumor Surgery
Navari Surgical AB
Phase NA Not yet recruiting
NCT07227012 2026-06-04
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Pfizer
Phase 1/2 Recruiting
NCT05211323 2026-06-03
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05063565 2026-06-01
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT06096779 2026-06-01
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT06600321 2026-06-01
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT06533332 2026-05-29
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
EtiraRx Australia Pty Ltd
Phase 1 Recruiting
NCT06851663 2026-05-29
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
Phase 2/3 Recruiting
NCT04196465 2026-05-22
NeoChance
Asan Medical Center
Phase 2 Active not recruiting
NCT06084884 2026-05-22
ATHENA
AstraZeneca
Phase 1/2 Active not recruiting
NCT06263088 2026-05-22
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT07377487 2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT07587034 2026-05-20
HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer
Shanghai Zhongshan Hospital
Phase 1/2 Not yet recruiting
NCT00629759 2026-05-19
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
SillaJen, Inc.
Phase 1 Completed
NCT02984566 2026-05-19
TROG1703 LARK
University of Sydney
Phase NA Active not recruiting
NCT05146297 2026-05-19
DISRUPT
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT06626087 2026-05-15
Hepatocellular
The University of Hong Kong
Phase NA Completed
NCT07224464 2026-05-15
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
Phase NA Recruiting
NCT07586046 2026-05-14
MARGIN
Northwestern University
Phase 2 Not yet recruiting